All Stories

  1. Parametric Response Mapping Monitors Temporal Changes on Lung CT Scans in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
  2. A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer
  3. Image Registration for Quantitative Parametric Response Mapping of Cancer Treatment Response
  4. Parametric Response Mapping as a Diagnostic Indicator of Bronchiolitis Obliterans Syndrome
  5. Impact of Perfusion Map Analysis on Early Survival Prediction Accuracy in Glioma Patients
  6. Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis
  7. Analysis and correction of gradient nonlinearity bias in apparent diffusion coefficient measurements
  8. Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression
  9. Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom
  10. Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis
  11. Voxel-Based Image Registration Analysis Of The COPD Lung
  12. CT-Based Biomarker Provides Diagnosis Of COPD Phenotypes
  13. Abstract 4066: Early assessment of the XL184 treatment by Diffusion-Weighted MRI in metastatic prostate cancer to the bone murine model
  14. Abstract 2355: Assessment of glioma recurrence following radiotherapy using the parametric response map: A preclinical study
  15. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model
  16. Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies
  17. Prospective Analysis of Parametric Response Map-Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment
  18. Abstract 4890: Diffusion-weighted MRI provides an early assessment of treatment response in a murine model of metastatic prostate cancer to the bone
  19. Assessment of multiexponential diffusion features as MRI cancer therapy response metrics
  20. Diffusion-Weighted MRI for Assessment of Early Cancer Treatment Response
  21. Predicting and monitoring cancer treatment response with diffusion-weighted MRI
  22. Abstract 2698: The parametric response map as an imaging biomarker for identifying progression from pseudoprogression in glioma patients
  23. Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma
  24. Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas
  25. DW-MRI Assessment of Cancer Response to Chemoradiation
  26. Diffusion Imaging for Therapy Response Assessment of Brain Tumor
  27. A Feasibility Study of Parametric Response Map Analysis of Diffusion-Weighted Magnetic Resonance Imaging Scans of Head and Neck Cancer Patients for Providing Early Detection of Therapeutic Efficacy
  28. The parametric response map is an imaging biomarker for early cancer treatment outcome
  29. Voxel-by-Voxel Functional Diffusion Mapping for Early Evaluation of Breast Cancer Treatment
  30. Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas
  31. Diffusion Magnetic Resonance Imaging: An Imaging Treatment Response Biomarker to Chemoradiotherapy in a Mouse Model of Squamous Cell Cancer of the Head and Neck
  32. Parametric Response Map Analysis as an Imaging Biomarker for Distinguishing Progression from Pseudo-progression in High Grade Gliomas
  33. Functional Diffusion Map As an Early Imaging Biomarker for High-Grade Glioma: Correlation With Conventional Radiologic Response and Overall Survival
  34. Radiation-Induced Changes in Normal-Appearing White Matter in Patients With Cerebral Tumors: A Diffusion Tensor Imaging Study
  35. A Feasibility Study Evaluating the Functional Diffusion Map as a Predictive Imaging Biomarker for Detection of Treatment Response in a Patient with Metastatic Prostate Cancer to the Bone
  36. S11 The functional diffusion map (fDM): an early predictive biomarker of tumor response
  37. Diffusion Imaging: Insight to Cell Status and Cytoarchitecture
  38. The Functional Diffusion Map: An Imaging Biomarker for the Early Prediction of Cancer Treatment Outcome
  39. Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors
  40. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma
  41. Evaluation of the Functional Diffusion Map (fDM) as an Early Biomarker of TTP and OS in High Grade Glioma
  42. Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response
  43. Use of Magnetic Resonance Imaging for Evaluation of Treatment Response
  44. Bioluminescence Detection of Cells Having Stabilized p53 in Response to a Genotoxic Event
  45. Diffusion MRI: A New Strategy for Assessment of Cancer Therapeutic Efficacy
  46. Rapid and Quantitative Assessment of Cancer Treatment Response Using In Vivo Bioluminescence Imaging
  47. Oxidative Stress in the Central Nervous System: Monitoring the Metabolic Response using the Pentose Phosphate Pathway
  48. Diffusion MR imaging in adult neoplasia
  49. Diffusion MR imaging in adult neoplasia